Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer - a podcast by Timmerman Report

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

Further episodes of The Long Run with Luke Timmerman

Further podcasts by Timmerman Report

Website of Timmerman Report